
### [MONDO:0018882](http://purl.obolibrary.org/obo/MONDO_0018882)
**Label:** vasculitis

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0018227](http://purl.obolibrary.org/obo/MONDO_0018227) (hypocomplementemic urticarial vasculitis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0017257](http://purl.obolibrary.org/obo/MONDO_0017257) (idiopathic posterior uveitis), [MONDO:0017212](http://purl.obolibrary.org/obo/MONDO_0017212) (paraneoplastic uveitis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0000498](http://purl.obolibrary.org/obo/MONDO_0000498) (arteritic anterior ischemic optic neuropathy), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0007407](http://purl.obolibrary.org/obo/MONDO_0007407) (Cryoglobulinemic vasculitis), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0012727](http://purl.obolibrary.org/obo/MONDO_0012727) (mucocutaneous lymph node syndrome), [MONDO:0006950](http://purl.obolibrary.org/obo/MONDO_0006950) (retinal vasculitis), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0011599](http://purl.obolibrary.org/obo/MONDO_0011599) (birdshot chorioretinopathy), [MONDO:0016848](http://purl.obolibrary.org/obo/MONDO_0016848) (juvenile temporal arteritis), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0014306](http://purl.obolibrary.org/obo/MONDO_0014306) (vasculitis due to ADA2 deficiency), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0009303](http://purl.obolibrary.org/obo/MONDO_0009303) (anti-glomerular basement membrane disease), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0008538](http://purl.obolibrary.org/obo/MONDO_0008538) (temporal arteritis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0015943](http://purl.obolibrary.org/obo/MONDO_0015943) (eosinophilic granulomatosis with polyangiitis), [MONDO:0019509](http://purl.obolibrary.org/obo/MONDO_0019509) (cutaneous leukocytoclastic angiitis), [MONDO:0017209](http://purl.obolibrary.org/obo/MONDO_0017209) (infectious posterior uveitis), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0016665](http://purl.obolibrary.org/obo/MONDO_0016665) (unclassified vasculitis), [MONDO:0016664](http://purl.obolibrary.org/obo/MONDO_0016664) (drug-induced vasculitis), [MONDO:0016425](http://purl.obolibrary.org/obo/MONDO_0016425) (Hughes-Stovin syndrome), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0015374](http://purl.obolibrary.org/obo/MONDO_0015374) (primary central nervous system vasculitis), [MONDO:0017991](http://purl.obolibrary.org/obo/MONDO_0017991) (Takayasu arteritis), [MONDO:0018640](http://purl.obolibrary.org/obo/MONDO_0018640) (secondary vasculitis), [MONDO:0015453](http://purl.obolibrary.org/obo/MONDO_0015453) (Cogan syndrome), [MONDO:0015491](http://purl.obolibrary.org/obo/MONDO_0015491) (immune complex mediated vasculitis), [MONDO:0015490](http://purl.obolibrary.org/obo/MONDO_0015490) (predominantly small-vessel vasculitis), [MONDO:0015492](http://purl.obolibrary.org/obo/MONDO_0015492) (Anti-neutrophil cytoplasmic antibody-associated vasculitis), [MONDO:0008889](http://purl.obolibrary.org/obo/MONDO_0008889) (thromboangiitis obliterans), [MONDO:0003346](http://purl.obolibrary.org/obo/MONDO_0003346) (central nervous system vasculitis), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0012105](http://purl.obolibrary.org/obo/MONDO_0012105) (Wegener's granulomatosis), [MONDO:0001280](http://purl.obolibrary.org/obo/MONDO_0001280) (choroiditis), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0014405](http://purl.obolibrary.org/obo/MONDO_0014405) (STING-associated vasculopathy with onset in infancy), [MONDO:0015488](http://purl.obolibrary.org/obo/MONDO_0015488) (predominantly large-vessel vasculitis), [MONDO:0019526](http://purl.obolibrary.org/obo/MONDO_0019526) (erythema elevatum diutinum), [MONDO:0015489](http://purl.obolibrary.org/obo/MONDO_0015489) (predominantly medium-vessel vasculitis), [MONDO:0019124](http://purl.obolibrary.org/obo/MONDO_0019124) (microscopic polyangiitis), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0019167](http://purl.obolibrary.org/obo/MONDO_0019167) (immunoglobulin a vasculitis), [MONDO:0018152](http://purl.obolibrary.org/obo/MONDO_0018152) (serpiginous choroiditis), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0002783](http://purl.obolibrary.org/obo/MONDO_0002783) (Shwartzman phenomenon), [MONDO:0005695](http://purl.obolibrary.org/obo/MONDO_0005695) (central nervous system AIDS arteritis), [MONDO:0006785](http://purl.obolibrary.org/obo/MONDO_0006785) (Henoch-Schoenlein purpura), [MONDO:0002341](http://purl.obolibrary.org/obo/MONDO_0002341) (granulomatous angiitis), [MONDO:0001290](http://purl.obolibrary.org/obo/MONDO_0001290) (allergic cutaneous vasculitis), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0018837](http://purl.obolibrary.org/obo/MONDO_0018837) (postinfectious vasculitis), [MONDO:0019726](http://purl.obolibrary.org/obo/MONDO_0019726) (type II mixed cryoglobulinemia), [MONDO:0019727](http://purl.obolibrary.org/obo/MONDO_0019727) (mixed cryoglobulinemia type III), 

**Mapped go classes:** [GO:0043103](http://purl.obolibrary.org/obo/GO_0043103) (hypoxanthine salvage), [GO:0032606](http://purl.obolibrary.org/obo/GO_0032606) (type I interferon production), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0032608](http://purl.obolibrary.org/obo/GO_0032608) (interferon-beta production), [GO:0035438](http://purl.obolibrary.org/obo/GO_0035438) (cyclic-di-GMP binding), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0046103](http://purl.obolibrary.org/obo/GO_0046103) (inosine biosynthetic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0032958](http://purl.obolibrary.org/obo/GO_0032958) (inositol phosphate biosynthetic process), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0071360](http://purl.obolibrary.org/obo/GO_0071360) (cellular response to exogenous dsRNA), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0019239](http://purl.obolibrary.org/obo/GO_0019239) (deaminase activity), [GO:0008440](http://purl.obolibrary.org/obo/GO_0008440) (inositol-1,4,5-trisphosphate 3-kinase activity), [GO:0004000](http://purl.obolibrary.org/obo/GO_0004000) (adenosine deaminase activity), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0006154](http://purl.obolibrary.org/obo/GO_0006154) (adenosine catabolic process), [GO:0061507](http://purl.obolibrary.org/obo/GO_0061507) (cyclic-GMP-AMP binding), [GO:0002230](http://purl.obolibrary.org/obo/GO_0002230) (positive regulation of defense response to virus by host), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:0043020](http://purl.obolibrary.org/obo/GO_0043020) (NADPH oxidase complex), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0031685](http://purl.obolibrary.org/obo/GO_0031685) (adenosine receptor binding), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0032092](http://purl.obolibrary.org/obo/GO_0032092) (positive regulation of protein binding), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0043394](http://purl.obolibrary.org/obo/GO_0043394) (proteoglycan binding), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0060837](http://purl.obolibrary.org/obo/GO_0060837) (blood vessel endothelial cell differentiation), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0042993](http://purl.obolibrary.org/obo/GO_0042993) (positive regulation of transcription factor import into nucleus), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0005777](http://purl.obolibrary.org/obo/GO_0005777) (peroxisome), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0039528](http://purl.obolibrary.org/obo/GO_0039528) (cytoplasmic pattern recognition receptor signaling pathway in response to virus), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.99%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.28%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.64%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005711](http://purl.obolibrary.org/obo/GO_0005711) (obsolete meiotic chromosome)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005710](http://purl.obolibrary.org/obo/GO_0005710) (obsolete metaphase chromosome)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005709](http://purl.obolibrary.org/obo/GO_0005709) (obsolete prophase chromosome)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005708](http://purl.obolibrary.org/obo/GO_0005708) (obsolete mitotic chromosome)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005707](http://purl.obolibrary.org/obo/GO_0005707) (obsolete interphase chromosome)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005699](http://purl.obolibrary.org/obo/GO_0005699) (null)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005698](http://purl.obolibrary.org/obo/GO_0005698) (obsolete centromere)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005696](http://purl.obolibrary.org/obo/GO_0005696) (obsolete telomere)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005695](http://purl.obolibrary.org/obo/GO_0005695) (obsolete chromatid)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0005679](http://purl.obolibrary.org/obo/GO_0005679) (null)) 36.64%


